These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10455479)

  • 1. Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide.
    Vanmolkot FH; de Hoon JN; van de Ven LL; Van Bortel LM
    J Hum Hypertens; 1999 Aug; 13(8):559-63. PubMed ID: 10455479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life comparison between bisoprolol and nifedipine retard in hypertension.
    de Hoon JN; Vanmolkot FH; van de Ven LL; Van Bortel LM
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):465-71. PubMed ID: 9310275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension.
    Isles CG; Kitchin NR
    J Hum Hypertens; 1999 Jan; 13(1):69-73. PubMed ID: 9928755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life.
    Bulpitt CJ; Connor M; Schulte M; Fletcher AE
    J Hum Hypertens; 2000 Mar; 14(3):205-12. PubMed ID: 10694836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
    Carlsen JE; Køber L; Torp-Pedersen C; Johansen P
    BMJ; 1990 Apr; 300(6730):975-8. PubMed ID: 2344503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
    Hosie J; Nasar MA; Belgrave GP; Walters EG
    Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind trial of captopril or bendrofluazide in newly diagnosed senile hypertension.
    Starr JM; Whalley LJ; Inch S; White A; Hadley L
    Curr Med Res Opin; 1994; 13(4):214-21. PubMed ID: 7882701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension.
    Harper R; Ennis CN; Sheridan B; Atkinson AB; Johnston GD; Bell PM
    BMJ; 1994 Jul; 309(6949):226-30. PubMed ID: 7818648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose bendrofluazide (1.25 mg) effectively lowers blood pressure over 24 h: results of a randomized, double-blind, placebo-controlled crossover study.
    Wiggam MI; Bell PM; Sheridan B; Walmsley A; Atkinson AB
    Am J Hypertens; 1999 May; 12(5):528-31. PubMed ID: 10342793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N; Lim PO; MacDonald TM
    Circulation; 2001 Jul; 104(5):511-4. PubMed ID: 11479245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group.
    Fletcher AE; Battersby C; Adnitt P; Underwood N; Jurgensen HJ; Bulpitt CJ
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):108-14. PubMed ID: 1383618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of antihypertensive effect by blood pressure monitoring: applications to bisoprolol and lisinopril in a double-blind study.
    Vaïsse B; Herpin D; Asmar R; Battistella P; Zannad F; Boutelant S; Lyon A; Conte D; Denis J; Honore P; Contard S; Prost PL; Mallion JM; Poggi L
    J Cardiovasc Pharmacol; 1997 May; 29(5):612-7. PubMed ID: 9213203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril.
    Breed JG; Ciampricotti R; Tromp GP; Valster FA; Lageweg E; Van Bortel LM
    J Cardiovasc Pharmacol; 1992; 20(5):750-5. PubMed ID: 1280737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.
    Deary AJ; Schumann AL; Murfet H; Haydock SF; Foo RS; Brown MJ
    J Hypertens; 2002 Apr; 20(4):771-7. PubMed ID: 11910315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients.
    Girvin B; Johnston GD
    J Hypertens; 1998 Jul; 16(7):1049-54. PubMed ID: 9794747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect long-term administration of a selective beta1 blocker bisoprolol on glucose metabolism in patients with essential hypertensive and type 2 diabetes mellitus].
    Wang B; Song WH; Liu GZ;
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):503-5. PubMed ID: 16080839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
    Benetos A; Consoli S; Safavian A; Dubanchet A; Safar M
    Am Heart J; 2000 Oct; 140(4):E11. PubMed ID: 11011336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A post-marketing acceptability study in 11,685 patients of the efficacy of timolol/bendrofluazide in the management of hypertension in general practice.
    Marsh BT; Atkins MJ; Talbot DJ; Fairey IT
    J Int Med Res; 1987; 15(2):106-14. PubMed ID: 3582721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.